Dr. Thomas Klaue, CFO of Medigene AG Has Been Selected for Inclusion in the 2007-2008 Princeton Premier Registry

Frankfurt, Germany, November 27, 2007 --(PR.com)-- Dr. Thomas Klaue, CFO of Medigene AG has been selected for inclusion in the 2007-2008 Princeton Premier Registry. Before joining MediGene, Dr. Klaue has been a partner at Fozzati Partners LLC, Frankfurt, a private investment bank where he acted as an advisor on business transactions for major financial investors. Prior to that he was Vice President Business Development with Infineon Technologies AG for more than five years, where he held several senior management positions. He established the emerging biochip business, managed the strategic investment group and the corporate venture capital fund, and was head of M&A, organizational development, and cooperations in the US, Europe, and Asia. Prior to that he was Vice President M&A at DaimlerChrysler Aerospace AG, Munich (today's EADS) for five years. Before that, he was the Director and head of department for the pharmaceutical and chemical industry at the Treuhandanstalt, Berlin, the federal organization in charge of privatizing the East German Economy, where he gained four years of experience in reorganization and privatization. Dr. Klaue is a chemical engineer and holds a doctorate in business economics. He obtained his management education at the MIT Sloan School and as a Harvard Business School graduate in Boston, USA.

Dr. Klaue spends most of his spare time coaching a team for the German Skiing Association. He also contributes to several local charities. Princeton Premier is proud to welcome Dr. Klaue to the 2007-2008 Registry.

About Princeton Premier:
Princeton Premier is the publisher of an exclusive registry comprised of business leaders and professionals making an impact in their industry and community. The online network is a large interactive business community where their valued members use the web based service daily as an online channel to assist them in meeting their specific business goals.

###